Aurora Cannabis: New Product Launch with CTT Pharma
Aurora Cannabis (ACB) strengthened its footing in the medical cannabis industry by launching a new product. The stock rose 2.1% in pre-market trading today.
Cannabis
Up to date news on the emerging cannabis sector as well as legislative developments affecting cannabis business in North America.
Aurora Cannabis versus Canopy Growth: A Valuation Update
As of October 4, Aurora Cannabis was trading at a forward EV-to-EBITDA multiple of 33.05x compared to 68.8x at the beginning of September.
Canopy Growth: Analysts’ Target Price and Ratings
Canopy Growth (WEED) (CGC) stock has been under pressure since it reported its earnings for the first quarter of fiscal 2020 on August 14.
Cannabis Samples Didn’t Pass Tests in Nevada
The Nevada Department of Taxation announced that four cannabis products sold between May 28 and July 10 failed the secondary microbial test.
Cannabis Legalization: Will Mexico Beat the US?
Cannabis regulation in Mexico is a key topic this week. The US, Canadian, and Mexican economies are more closely intertwined than other countries.
Curaleaf Comes Out with Cannabis Tablets in Florida
Yesterday, Curaleaf became the first company to launch medical cannabis tablets in Florida. It’s made these tablets available at all state dispensaries.
Aurora Cannabis Stock Fell Approximately 9%: Time to Buy?
Aurora Cannabis posted its fourth-quarter earnings after the market closed on Wednesday. The company posted revenues of 98.9 million Canadian dollars.
Aurora Cannabis: Investors Are Optimistic about Q4 Earnings
Aurora Cannabis (ACB) stock has been rising before its fourth-quarter earnings on Thursday. The stock has risen 12.4% this month.
New Cannabis Products to Follow Edibles Legalization
Canada’s next wave of cannabis legalization allows edibles, beverages, extracts, and topicals on October 17. The products could hit the stores in December.
CannTrust: The Bad News Keeps Pouring In
CannTrust (CTST) was hit with selling pressure this morning as its stock declined almost 5%. However, the overall cannabis sector seems to be positive
Cannabis Legalization: Did President Trump Drop a Hint?
Cannabis legalization is a hot topic. With the sudden boom in the cannabis industry, legalization at the national level is vital.
HEXO: What Does Jim Cramer Think?
HEXO reported its third-quarter earnings on June 12. The company reported revenues of $13.0 million, which fell short of analysts’ estimate.
Can Marijuana Legalization Spark Beto O’Rourke’s Bid?
Marijuana reform is central to Beto O’Rourke’s 2020 presidential campaign—how could his agenda that affect the cannabis industry?
Why Ex-CEO Bruce Linton Still Believes in Canopy Growth
Few news items this summer jolted the legalized cannabis industry quite like the termination of former co-CEO Bruce Linton from Canopy Growth Corp.
Canopy Growth Earnings Impacted the Cannabis Sector
Canopy Growth’s weak results weighed on the entire cannabis sector. Most of the cannabis stocks were in the red on Thursday.
Aurora Cannabis Acquires Hempco Food and Fiber
Aurora Cannabis (ACB) was trading lower early this morning after falling about 8% last week. It has Aurora completed its Hempco Food and Fiber acquisition.
Cresco Labs Stock Tumbling ahead of Earnings
Cresco Labs (CRLBF) is set to report its Q2 earnings on August 21 after the market closes. The company’s stock fell 5.3% yesterday.
Canopy Growth Stock Tanks after Q1 Earnings
Canopy Growth (WEED)(CGC) reported its earnings after the market closed on August 14, and the stock plunged as a result. What went wrong?
Why Mike Tyson Is Talking about Cannabis
CNN reported that heavyweight champion Mike Tyson said they smoke 10 tons of weed, worth about $40,000, at his California marijuana ranch per month.
Key Takeaways from Acreage Holdings’ Q2 Earnings
Acreage Holdings reported its second-quarter earnings results on August 13. The company reported stellar revenue growth of $17.7 million.
MedMen Reports Its Preliminary Revenue for Q4
Today, MedMen Enterprises (MMEN) (MMNFF) reported its unaudited revenue for the fourth quarter of fiscal 2019.
Why Jim Cramer Favors CRON and CGC
Canopy Growth (CGC) rose 1.5% today while Cronos Group (CRON) fell 3.8%. CNBC host Jim Cramer favors both stocks amid several weed industry scandals.
Joe Biden Wants to Reform Cannabis Laws
Joe Biden wants to change the criminal justice system because he “believes no one should be in jail because of cannabis use.”
What to Expect for Canopy Growth’s Earnings
Canopy Growth (WEED)(CGC) is set to announce its fiscal 2020 first-quarter results on August 14. Market participants are eager to see how it did.
Kroger Deal Ignited Charlotte’s Web Holdings Last Week
Charlotte’s Web Holdings’ Kroger deal ignited the stock last week. The stock saw an upwards price action of almost 42%. The stock has risen 86% this year.
Aphria Stock Rises on Earnings Beat
Aphria (APHA) reported its earnings results for Q4 and fiscal 2019 after the market closed today. Will the positive results lift cannabis sentiment overall?
Cannabis Outlook From OrganiGram’s Earnings Report
On Monday, OrganiGram (OGI) reported its third-quarter earnings. Following the company’s earnings, we reported how it performed in the third quarter. To learn more, read OrganiGram’s Third-Quarter Earnings. Form factors Interestingly, OrganiGram stressed that the growth would be heavily driven by retail stores opening in Ontario and Quebec. The company stated that legalizing edibles and […]
OrganiGram’s Third-Quarter Earnings
On Monday morning, OrganiGram’s third-quarter earnings came in as a bit of a let-down. Here’s why.Cannabis Curaleaf’s Revenues: Analysts’ Expectations in 2019
Fourth-quarter revenues Before we discuss analysts’ 2019 estimates, we’ll look at Curaleaf Holdings’ (CURA) (CURLF) fourth-quarter performance. The company posted its earnings on March 20. For the quarter ending on December 31, Curaleaf posted revenues of $32.0 million—49.6% growth from $21.4 million in the third quarter of 2018. The company’s revenues rose 408.9% year-over-year. The revenue growth was […]